Kumar T K Susheel, Subramanian Saradha, Tansey James Benjamin, Figueroa Mayte, Zurakowski David, Allen Jerry, Shah Samir, Brauninger Anna, Bird Lindsey, Ali Mohammed, Knott-Craig Christopher J
Department of Pediatric Cardiothoracic Surgery, Le Bonheur Children's Hospital and University of Tennessee Health Science Center, Memphis, TN, USA.
Department of Pediatric Cardiology, Le Bonheur Children's Hospital and University of Tennessee Health Science Center, Memphis, TN, USA.
Interact Cardiovasc Thorac Surg. 2017 Dec 1;25(6):883-886. doi: 10.1093/icvts/ivx204.
The transthoracic intracardiac line placed in the right atrium provides a convenient access to the central venous system following cardiac surgery. However, it is associated with risks such as migration and bleeding. We conducted a retrospective study to determine whether position of transthoracic line with respect to site of exit from the chest makes a difference in the rate of complications.
All infants receiving a transthoracic intracardiac line in the right atrium following cardiac surgery between June 2012 and December 2015 were part of the study. A 3.5-Fr double-lumen umbilical venous catheter was placed directly into the right atrium. The lines exited the thorax either above in the suprasternal notch (upper transthoracic line) or below the diaphragm across the abdominal wall (lower transthoracic line). Patients were analysed for complications such as catheter migration, bleeding upon removal, atrial thrombus, line occlusion, premature removal and failed removal.
A total of 131 patients received a transthoracic intracardiac line during the study period. Of the total patients, 88 patients received the upper transthoracic line and 43 patients received the lower transthoracic line. The upper transthoracic line was associated with significantly lower incidence of catheter migration (1% vs 14%) and this held by multivariable logistic regression, adjusting for age and duration of the line (P = 0.003). There was no difference in the rate of other complications including bleeding.
The upper transthoracic line is associated with significantly lower incidence of catheter migration and offers a more optimum position for central access following cardiac surgery.
放置于右心房的经胸心内导管为心脏手术后进入中心静脉系统提供了便利途径。然而,它存在诸如移位和出血等风险。我们进行了一项回顾性研究,以确定经胸导管相对于胸部出口部位的位置是否会影响并发症发生率。
2012年6月至2015年12月期间所有在心脏手术后接受经胸右心房心内导管的婴儿均纳入本研究。将一根3.5F双腔脐静脉导管直接置入右心房。导管经胸骨上切迹上方(经胸上线)或经腹壁横过膈肌下方(经胸下线)穿出胸腔。对患者的并发症进行分析,如导管移位、拔除时出血、心房血栓、导管堵塞、过早拔除和拔除失败。
研究期间共有131例患者接受了经胸心内导管。在所有患者中,88例接受经胸上线,43例接受经胸下线。经胸上线与导管移位发生率显著较低相关(1%对14%),多变量逻辑回归分析在调整年龄和导管留置时间后此结果依然成立(P = 0.003)。包括出血在内的其他并发症发生率无差异。
经胸上线与导管移位发生率显著较低相关,为心脏手术后中心静脉通路提供了更理想的位置。